Dashboard
Manage Tickers

TXG10x Genomics, Inc.

Nasdaq 10xgenomics.com


$ 22.44 $ 0.01 (0.04 %)    

Friday, 31-May-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 22.42
$ 22.56
$ 0.00 x 0
$ 0.00 x 0
$ 22.07 - $ 22.87
$ 21.74 - $ 63.57
1,381,357
na
2.68B
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-16-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-18-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

10x-genomics-launches-xenium-prime-5k-pan-tissue-and-pathways-panel
10x Genomics Launches Xenium Prime 5K Pan-...
05/29/2024 20:36:11

 New Xenium Prime 5K Pan-Tissue and Pathways panel increases plex by an order of magnitude and delivers industry-leading speed ...

cathie-woods-ark-innovation-etf-sees-sharp-decline-among-top-holdings--here-are-10-largest-losers-within-arkf
Cathie Wood's Ark Innovation ETF Sees Shar...
05/28/2024 11:29:37

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced b...

Core News & Articles
German Federal Patent Court Invalidates Eu...
05/07/2024 18:09:43

Core News & Articles
German Federal Patent Court Invalidates Pa...
05/07/2024 18:08:08

NanoString, now a Bruker business, will promptly seek an end to the injunction impacting sales of CosMx SMI products in Germany...

ubs-maintains-neutral-on-10x-genomics-lowers-price-target-to-30
UBS Maintains Neutral on 10x Genomics, Low...
05/01/2024 17:34:33

UBS analyst Dan Leonard maintains 10x Genomics (NASDAQ:TXG) with a Neutral and lowers the price target from $52 to $30.

b-of-a-securities-maintains-neutral-on-10x-genomics-lowers-price-target-to-36
B of A Securities Maintains Neutral on 10x...
05/01/2024 17:10:13

B of A Securities analyst Derik De Bruin maintains 10x Genomics (NASDAQ:TXG) with a Neutral and lowers the price target from...

goldman-sachs-maintains-sell-on-10x-genomics-lowers-price-target-to-26
Goldman Sachs Maintains Sell on 10x Genomi...
05/01/2024 16:39:42

Goldman Sachs analyst Matthew Sykes maintains 10x Genomics (NASDAQ:TXG) with a Sell and lowers the price target from $30 to ...

td-cowen-downgrades-10x-genomics-to-hold-lowers-price-target-to-32
TD Cowen Downgrades 10x Genomics to Hold, ...
05/01/2024 16:27:36

TD Cowen analyst Dan Brennan downgrades 10x Genomics (NASDAQ:TXG) from Buy to Hold and lowers the price target from $57 to $32.

stifel-maintains-buy-on-10x-genomics-lowers-price-target-to-53
Stifel Maintains Buy on 10x Genomics, Lowe...
05/01/2024 13:01:52

Stifel analyst Daniel Arias maintains 10x Genomics (NASDAQ:TXG) with a Buy and lowers the price target from $63 to $53.

the-european-unified-patent-court-clears-curio-seeker-with-respect-to-claim-1-of-ep-2697391-asserted-by-10x-genomics
The European Unified Patent Court Clears C...
05/01/2024 07:27:49

The European Unified Patent Court (UPC) today announced a finding that Curio Seeker does not infringe main claim 1 of EP 269739...

10x-genomics-maintains-2024-revenue-guidance-of-670m-690m-est-67779m-representing-8-12-growth-yy
10x Genomics Maintains 2024 Revenue Guidan...
04/30/2024 21:06:26

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 20:31:25

10x-genomics-q1-2024-gaap-eps-050-misses-048-estimate-sales-141006m-miss-142245m-estimate
10x Genomics Q1 2024 GAAP EPS $(0.50) Miss...
04/30/2024 20:11:37

10x Genomics (NASDAQ:TXG) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.48)...

canaccord-genuity-maintains-buy-on-10x-genomics-lowers-price-target-to-50
Canaccord Genuity Maintains Buy on 10x Gen...
04/29/2024 14:44:44

Canaccord Genuity analyst Kyle Mikson maintains 10x Genomics (NASDAQ:TXG) with a Buy and lowers the price target from $65 to...

geopolitical-relief-triggers-gold-selloff-prices-dip-below-2350-mark-mining-stocks-hit-hard
Geopolitical Relief Triggers Gold Selloff:...
04/22/2024 20:07:50

Gold prices declined 2.7% in NY due to reduced geopolitical risks. Silver also fell 5.1%. Israeli officials averted a US-backed...

the-analyst-landscape-4-takes-on-10x-genomics
The Analyst Landscape: 4 Takes On 10x Geno...
04/18/2024 17:00:24

deutsche-bank-maintains-buy-on-10x-genomics-lowers-price-target-to-55
Deutsche Bank Maintains Buy on 10x Genomic...
04/18/2024 12:13:06

Deutsche Bank analyst Justin Bowers maintains 10x Genomics (NASDAQ:TXG) with a Buy and lowers the price target from $60 to $55.

barclays-maintains-overweight-on-10x-genomics-lowers-price-target-to-45
Barclays Maintains Overweight on 10x Genom...
04/10/2024 19:38:33

Barclays analyst Luke Sergott maintains 10x Genomics (NASDAQ:TXG) with a Overweight and lowers the price target from $55 to ...

cathie-woods-ark-invest-sheds-64m-worth-of-coinbase-shares-despite-positive-market-movements-analyst-upgrade
Cathie Wood's Ark Invest Sheds $6.4M Worth...
04/05/2024 03:03:25

On Thursday, Cathie Wood-led Ark Invest made a significant move by selling shares of Coinbase Global Inc (NASDAQ:COIN), despite...

10x-genomics-launches-visium-hd-spatial-gene-expression-assay
10x Genomics Launches Visium HD Spatial Ge...
03/26/2024 13:06:24

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION